Impact of an immersive, interactive medical education initiative on guideline-based retinal disease management knowledge/competence and effectual practice change

Background Retinal diseases, including wet or dry age-related macular degeneration, diabetic macular edema, and diabetic retinopathy (DR), are underdiagnosed and undertreated in the United States. Clinical trials support the effectiveness of anti-vascular endothelial growth factor (anti-VEGF) therap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC ophthalmology Jg. 23; H. 1; S. 285 - 13
Hauptverfasser:	Singh, Rishi P., Welch, Lauren, Longo, Nicole L., Frese, Matt
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 22.06.2023 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Age Age-related macular degeneration Analysis Angiogenesis Inhibitors - therapeutic use Anti-vascular endothelial growth factor Behavior Care and treatment Clinical medicine Clinical trials Continuing education Diabetes Diabetes mellitus Diabetic macular edema Diabetic retinopathy Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Disease Disease Management Edema Education, Medical Eyes & eyesight Health care Health care industry Humans Intravitreal Injections Knowledge Macular degeneration Macular Edema - drug therapy Medical education Medical personnel Medicine Medicine & Public Health Nurse practitioners Ophthalmology Optometrists Optometry Patient education Patients Practice guidelines (Medicine) Primary care Ranibizumab - therapeutic use Registered nurses Retina Retinal disease Retinopathy Training Vascular endothelial growth factor Vascular Endothelial Growth Factor A United States > US Continuing education Macular degeneration Retinal vein occlusion Diabetic retinopathy Anti-vascular endothelial growth factor Age-related macular degeneration Diabetic macular edema Anti-VEGF Retinal disease Guideline-based treatment
ISSN:	1471-2415, 1471-2415
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!